Berkshire Drug Development Consulting LLC is categorized under Business Consultants in Lenox, MA and active since 2012.
Berkshire Drug Development Consulting LLC was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Thomas C Wessel at the company’s single location by writing to 22 Cliffwood St, Lenox, Massachusetts MA 01240 or by phoning (413) 464-1047. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Berkshire Drug Development Consulting LLC |
| Contact Person: | Thomas C Wessel |
| Address: | 22 Cliffwood St, Lenox, Massachusetts 01240 |
| Phone Number: | (413) 464-1047 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Berkshire Drug Development Consulting LLC was started in 2012 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Thomas C Wessel for inquiries that concern Berkshire Drug Development Consulting LLC by calling the company number (413) 464-1047, as your correspondence is most welcome. Additionally, the physical location of the single location of Berkshire Drug Development Consulting LLC can be found at the coordinates 42.360732,-73.284607 as well as the street address 22 Cliffwood St in Lenox, Massachusetts 01240.
For its online presence, you may visit Berkshire Drug Development Consulting LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.